Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Hainsworth

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
The Oncologist|October 21, 2000
Monoclonal antibody therapy in lymphoid malignanciesJ D Hainsworth
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancerJ D Hainsworth
Seminars in Oncology|February 28, 2001
Rituximab as first-line systemic therapy for patients with low-grade lymphomaJ D Hainsworth
Seminars in Surgical Oncology|May 1, 1993
Development of serotonin antagonists for the control of chemotherapy-induced emesisJ D Hainsworth
European Journal of Cancer Care|February 14, 1998
Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxelJ D Hainsworth
Drugs|March 11, 2000
Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issuesJ D Hainsworth
Seminars in Oncology|August 1, 1992
The use of ondansetron in patients receiving multiple-day cisplatin regimensJ D Hainsworth
Seminars in Oncology|February 1, 1995
The use of mitoxantrone in the treatment of breast cancerJ D Hainsworth
American Family Physician|May 1, 1997
Chemotherapy in the treatment of non-small cell lung cancerJ D Hainsworth
Archives of Internal Medicine|October 23, 1995
Treating advanced cancer in an era of increasing cost consciousnessJ D Hainsworth
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
The Oncologist|October 21, 2000
Monoclonal antibody therapy in lymphoid malignanciesJ D Hainsworth
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancerJ D Hainsworth
Seminars in Oncology|February 28, 2001
Rituximab as first-line systemic therapy for patients with low-grade lymphomaJ D Hainsworth
Seminars in Surgical Oncology|May 1, 1993
Development of serotonin antagonists for the control of chemotherapy-induced emesisJ D Hainsworth
European Journal of Cancer Care|February 14, 1998
Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxelJ D Hainsworth
Drugs|March 11, 2000
Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issuesJ D Hainsworth
Seminars in Oncology|August 1, 1992
The use of ondansetron in patients receiving multiple-day cisplatin regimensJ D Hainsworth
Seminars in Oncology|February 1, 1995
The use of mitoxantrone in the treatment of breast cancerJ D Hainsworth
American Family Physician|May 1, 1997
Chemotherapy in the treatment of non-small cell lung cancerJ D Hainsworth
Archives of Internal Medicine|October 23, 1995
Treating advanced cancer in an era of increasing cost consciousnessJ D Hainsworth
Pageof 21